ALERT!
Click here to register with a few steps and explore all our cool stuff we have to offer!
Home
Upgrade
Credits
Help
Search
Awards
Achievements
 149

mspo Impax completes pound;287m fundraising for its green power private equity pot

by DennisereBep - 06-08-2026 - 02:26 AM
#1
Ilyq The entrepreneur space race: Amazon rsquo Jeff Bezos takes on Elon Musk, Richard Branson, Larry Page and Eric Schmidt in the fight for space exploration
Tuesday 21 October 2014 8:22 pm|Updated:Wednesday 29 May 2019 6:42 pmF brumate TSE 100 rebounds as oil price rises and Shire jumps on bid report ndash; London ReportBy: Express KCSShareFacebookShare on FacebookXShare on TwitterLinkedInShare on LinkedInWhatsAppShare on WhatsAppEmailShare on Em stanley cup ailAdd as a preferredsource on GoogleGains in big oil companies and drugmaker Shire yesterday lifted Britainrsquo top equity index, which extended a rebound after falling to 15-month lows last week.The FTSE 100 index closed up b stanley cup canada y 1.7 per cent, or 105.26 points, at 6,372.33 points.Shire rose 2.61 per cent to 3,848p, after Reuters reported that Botox-maker Allergan shareholder Paulson Co was urging the firm to merge with the British drugmaker as an alternative to a deal with hostile bidder Valeant Pharmashy;ceuticals.With Brent crude edging higher after recent falls, helped by the Chinese GDP data, oil companies moved higher. Tullow Oil added 3.54 per cent to 526.50p, while Royal Dutch Shell A shares rose 3.07 per cent to 2163.50p. BP was up 2.79 per cent at 433.65p. Travel companies recovered some ground after fears over the deadly Ebola virus subsided. British Airways owner International Airlines Group rose 2.38 per cent to 370p, cruise company Carnival climbed 4.5 per cent to 2,347p, while Thomas Cook added 6.99 per cent to 117.80p. Share this articleFacebookXLinkedInWhatsAppEmailSimilarly tagged content: SectionsNewsCategoriesBusinessRelated TopicsOil pricesTrending ArticlesLabour wil Hwms Fears see Irish bond sell-off
Wednesday 21 August 2013 8:29 pmHikma lifts forecasts on surge in generics salesBy: Express K stanley deutschland CSShareFacebookShare on FacebookXShare on TwitterLinkedInShare on LinkedInWhatsAppShare on WhatsAppEmailShare on EmailAdd as a preferredsource on GoogleHIKMA Pharmaceuticals raised its full-year revenue forecast for the third time in four months yesterday, riding on strong sales of generic antibiotic doxycycline, a drug used to prevent and treat malaria and other infections.The company, which makes and sells both patented and generic drugs, said it expected total revenue to rise 20 per cent in 2013, up from its previous forecast of 17 polene cyme per cent.Group revenue increased by an annualised 19.9 per cent to $638.3m pound;407m in the six months ended 30 June, with earnings before interest, tax, depreciation and amortisation Ebitda jumping over 76 per cent from the same time a year earlier, to $182.6m.There is a shortage of doxycycline in the United States due to manufacturing issues, according to the US Food and Drug Administration. The regulator said demand for the drug has increas stanley at ed due to shortage of substitute drugs. Hikmarsquo generics arm is benefiting from exceptional sales of doxycycline, chief executive Said Darwazah explained.Hikmarsquo shares shot up more than three per cent yesterday morning, but deflated along with the rest of the market to end up 0.46 per cent at 1,095p. Share this articleFacebookXLinkedInWhatsAppEmailSimilarly tagged content: SectionsNe
Reply

Users browsing: 1 Guest(s)